Financhill
Back

Recursion Pharmaceuticals Quote, Financials, Valuation and Earnings

Recursion Pharmaceuticals Price Quote

$6.81
-0.12 (-1.73%)
(Updated: September 20, 2024 at 6:55 PM ET)

Recursion Pharmaceuticals Key Stats

Sell
46
Recursion Pharmaceuticals (RXRX) is a Sell

Day range:
$6.90 - $7.24
52-week range:
$4.97 - $15.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
32.59
P/B ratio:
3.35%

Volume:
4M
Avg. volume:
5M
1-year change:
-17.89%
Market cap:
$2B
Revenue:
$43.9M
EPS:
$-1.64

How Much Does Recursion Pharmaceuticals Make?

Is Recursion Pharmaceuticals Growing As A Company?

Recursion Pharmaceuticals Stock Price Performance

What Is Recursion Pharmaceuticals 52-Week High & Low?

Recursion Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Recursion Pharmaceuticals?

Is Recursion Pharmaceuticals Cash Flow Positive?

  • What Is RXRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$331.5M
  • What Is Recursion Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $411.4M
  • What Is Recursion Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$13.7M

Recursion Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RXRX return on invested capital is -78.34%
  • What Is Recursion Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -57.07%
  • What Is RXRX Return On Equity?
    ROE is a measure of profitability and is -79.57%

Recursion Pharmaceuticals Earnings Date & Stock Price

Recursion Pharmaceuticals Competitors

Recursion Pharmaceuticals Dividend Yield

Recursion Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -4.22%
Revenue: 30.76% 8.52%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 10.14
Upside from Last Price: 46.36%

Major Shareholders

  • How many RXRX shares are owned by institutional investors?
    357.3M RXRX shares are owned by institutional investors
  • How many RXRX shares are owned by insiders?
    11.1M RXRX shares are owned by insiders